CORZNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZR, CORZW, CORZZ
Core Scientific, Inc./tx
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$13.73+0.25 (+1.85%)
Close on Oct 19, 2026
- Market cap
- $4.47B
- P/E (TTM)
- –
- Dividend yield
- –
Core Scientific statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Finance Services companies for comparison
Valuation
| Measure | Core Scientific | Industry median |
|---|---|---|
| Market Cap | $4.41B | $199.16M |
| Enterprise Value | $6.94B | $160.19M |
| PS Ratio | 10.02 | 2.66 |
| P/OCF Ratio | 8.48 | 5.61 |
Enterprise value
| Measure | Core Scientific | Industry median |
|---|---|---|
| EV / Sales | 15.76 | 2.72 |
Income (trailing twelve months)
| Measure | Core Scientific | Industry median |
|---|---|---|
| Revenue | $440.31M | $61.19M |
| Gross Profit | $124.81M | $1.92M |
| Operating Income | -$561.16M | -$13.20M |
| Pretax Income | -$1.43B | -$4.81M |
| Net Income | -$1.43B | -$5.16M |
| EBITDA | -$498.59M | -$9.49M |
Margins
| Measure | Core Scientific | Industry median |
|---|---|---|
| Gross Margin | 28.3% | 43.9% |
| Operating Margin | -127.4% | -125.1% |
| Pretax Margin | -324.3% | -25.1% |
| Profit Margin | -324.9% | -21.0% |
| EBITDA Margin | -113.2% | -67.0% |
| FCF Margin | -217.5% | -22.8% |
Returns
| Measure | Core Scientific | Industry median |
|---|---|---|
| Return on Assets (ROA) | -40.3% | -11.8% |
| Return on Capital Employed (ROCE) | -22.3% | -23.7% |
Growth
| Measure | Core Scientific | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 26.4% | 19.7% |
| Revenue Growth (3Y CAGR) | -20.7% | 5.53% |
| Revenue Growth (5Y CAGR) | 39.5% | 10.1% |
Balance sheet
| Measure | Core Scientific | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.77B | $20.81M |
| Total Debt | $4.30B | $52.25M |
| Net Cash (Debt) | -$2.53B | $7.60M |
| Net Cash Per Share | -$7.87 | $0.22 |
| Equity (Book Value) | -$2.42B | $165.65M |
| Book Value Per Share | -$7.53 | $3.80 |
| Tangible Book Value | -$2.65B | $127.24M |
| Working Capital | -$294.15M | $8.71M |
Financial position
| Measure | Core Scientific | Industry median |
|---|---|---|
| Current Ratio | 0.89 | 1.43 |
| Quick Ratio | 0.65 | 0.54 |
Cash flow (trailing twelve months)
| Measure | Core Scientific | Industry median |
|---|---|---|
| Operating Cash Flow | $520.24M | -$5.36M |
| Capital Expenditures | -$1.48B | -$5.04M |
| Free Cash Flow | -$957.75M | -$15.68M |
| FCF Per Share | -$2.98 | -$0.26 |
Efficiency
| Measure | Core Scientific | Industry median |
|---|---|---|
| Asset Turnover | 0.12 | 0.16 |
| Revenue Per Employee | $1.35M | $705.30K |
| Profits Per Employee | -$4.40M | -$252.56K |
| Employee Count | 325 | 48 |
Dividends and yields
| Measure | Core Scientific | Industry median |
|---|---|---|
| Earnings Yield | -32.4% | -10.6% |
| FCF Yield | -21.7% | -13.8% |
Shares
| Measure | Core Scientific | Industry median |
|---|---|---|
| Shares Outstanding | 321,340,000 | 56,031,200 |
| Shares Change (YoY) | 3.96% | 12.9% |
| Shares Change (QoQ) | 0.83% | 0.24% |
| Float | 283,528,000 | 43,350,400 |
| Shares Held by Insiders | 11.8% | 18.5% |
| Shares Held by Institutions | 135.6% | 34.2% |
Taxes
| Measure | Core Scientific | Industry median |
|---|---|---|
| Income Tax | $2.73M | $82.74K |
Scores
| Measure | Core Scientific | Industry median |
|---|---|---|
| Altman Z-Score | -1.50 | 0.30 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Core Scientific's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.